• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1.5T磁共振直线加速器上前列腺表观扩散系数值的可重复性和再现性

Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator.

作者信息

Fernando Nitara, Tadic Tony, Li Winnie, Patel Tirth, Padayachee Jerusha, Santiago Anna T, Dang Jennifer, Chung Peter, Gutierrez Enrique, Coolens Catherine, Taylor Edward, Winter Jeff D

机构信息

Medical Biophysics, Western University, London, Ontario, Canada.

Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

出版信息

Phys Imaging Radiat Oncol. 2024 Mar 15;30:100570. doi: 10.1016/j.phro.2024.100570. eCollection 2024 Apr.

DOI:10.1016/j.phro.2024.100570
PMID:38544680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10966090/
Abstract

BACKGROUND AND PURPOSE

Integrated magnetic resonance linear accelerator (MR-Linac) systems offer potential for biologically based adaptive radiation therapy using apparent diffusion coefficient (ADC). Accurate tracking of longitudinal ADC changes is key to establishing ADC-driven dose adaptation. Here, we report repeatability and reproducibility of intraprostatic ADC using deformable image registration (DIR) to correct for inter-fraction prostate changes.

MATERIALS AND METHODS

The study included within-fraction repeat ADC measurements for three consecutive fractions for 20 patients with prostate cancer treated on a 1.5 T MR-Linac. We deformably registered successive fraction T-weighted images and applied the deformation vector field to corresponding ADC maps to align to fraction 2. We delineated gross tumour volume (GTV), peripheral zone (PZ) and prostate clinical target volume (CTV) regions-of-interest (ROIs) on T-weighted MRI and copied to ADC maps. We computed intraclass correlation coefficients (ICC) and percent repeatability coefficient (%RC) to determine within-fraction repeatability and between-fraction reproducibility for individual voxels, mean and 10th percentile ADC values per ROI.

RESULTS

The ICC between repeats and fractions was excellent for mean and 10th percentile ADC in all ROIs (ICC > 0.86), and moderate repeatability and reproducibility existed for individual voxels (ICC > 0.542). Similarly, low %RC within-fraction (4.2-17.9 %) mean and 10th percentile ADC existed, with greater %RC between fractions (10.2-36.8 %). Higher %RC existed for individual voxel within-fraction (21.7-30.6 %) and between-fraction (32.1-34.5 %) ADC.

CONCLUSIONS

Results suggest excellent ADC repeatability and reproducibility in clinically relevant ROIs using DIR to correct between-fraction anatomical changes. We established the precision of voxel-level ADC tracking for future biologically based adaptation implementation.

摘要

背景与目的

集成磁共振直线加速器(MR-Linac)系统为基于表观扩散系数(ADC)的生物适应性放射治疗提供了可能。准确跟踪纵向ADC变化是建立ADC驱动的剂量适应性的关键。在此,我们报告使用可变形图像配准(DIR)校正分次间前列腺变化后前列腺内ADC的重复性和再现性。

材料与方法

本研究纳入了20例在1.5T MR-Linac上接受治疗的前列腺癌患者,对其连续三个分次进行分次内重复ADC测量。我们对连续分次的T加权图像进行可变形配准,并将变形矢量场应用于相应的ADC图,使其与第二个分次对齐。我们在T加权MRI上勾勒出大体肿瘤体积(GTV)、外周带(PZ)和前列腺临床靶体积(CTV)感兴趣区(ROI),并复制到ADC图上。我们计算组内相关系数(ICC)和百分重复性系数(%RC),以确定每个体素、每个ROI的平均ADC值和第10百分位数ADC值的分次内重复性和分次间再现性。

结果

所有ROI中,平均ADC值和第10百分位数ADC值在重复测量和分次间的ICC均极佳(ICC>0.86),个体体素的重复性和再现性中等(ICC>0.542)。同样,分次内平均ADC值和第10百分位数ADC值的%RC较低(4.2-17.9%),分次间的%RC较高(10.2-36.8%)。个体体素分次内(21.7-30.6%)和分次间(32.1-34.5%)ADC的%RC更高。

结论

结果表明,使用DIR校正分次间解剖变化后,临床相关ROI中的ADC具有出色的重复性和再现性。我们建立了体素级ADC跟踪的精度,以便未来实施基于生物学的适应性放疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/855da8ada241/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/dddbbd863c72/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/9fa7a09a3bf1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/c91d79587e50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/9c3dc6497572/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/855da8ada241/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/dddbbd863c72/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/9fa7a09a3bf1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/c91d79587e50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/9c3dc6497572/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebd5/10966090/855da8ada241/gr4.jpg

相似文献

1
Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator.1.5T磁共振直线加速器上前列腺表观扩散系数值的可重复性和再现性
Phys Imaging Radiat Oncol. 2024 Mar 15;30:100570. doi: 10.1016/j.phro.2024.100570. eCollection 2024 Apr.
2
Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.前列腺的多参数磁共振成像:体积和表观扩散系数定量的可重复性
Invest Radiol. 2017 Sep;52(9):538-546. doi: 10.1097/RLI.0000000000000382.
3
Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.1.5TMR-Linac 上进行的磁共振引导放射治疗的前列腺癌患者的表观扩散系数(ADC)的纵向监测:一项前瞻性可行性研究。
Radiol Oncol. 2023 Jun 21;57(2):184-190. doi: 10.2478/raon-2023-0020. eCollection 2023 Jun 1.
4
Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients.在中枢神经系统肿瘤患者的 1.5T MR-Linac 上进行表观扩散系数测量的准确性和精密度。
Radiother Oncol. 2021 Nov;164:155-162. doi: 10.1016/j.radonc.2021.09.020. Epub 2021 Sep 28.
5
Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac.在低场强磁共振直线加速器中对未来临床应用的脑扩散加权成像进行可重复性量化。
Radiat Oncol. 2024 Mar 6;19(1):31. doi: 10.1186/s13014-024-02424-7.
6
Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac.头部和颈部癌症在 1.5T MR-Linac 上的扩散加权磁共振成像的可重复性。
Radiother Oncol. 2022 Sep;174:141-148. doi: 10.1016/j.radonc.2022.07.020. Epub 2022 Jul 25.
7
Reliability of MRI radiomics features in MR-guided radiotherapy for prostate cancer: Repeatability, reproducibility, and within-subject agreement.MRI 放射组学特征在前列腺癌 MR 引导放疗中的可靠性:重复性、可再现性和个体内一致性。
Med Phys. 2021 Nov;48(11):6976-6986. doi: 10.1002/mp.15232. Epub 2021 Sep 25.
8
Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.PI-RADS 病灶平均 ADC 值的日内重复性和序列间可重复性。
Eur J Radiol. 2023 Aug;165:110898. doi: 10.1016/j.ejrad.2023.110898. Epub 2023 Jun 8.
9
Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration.源自胶质母细胞瘤浸润多参数磁共振成像模型的放射治疗剂量描绘处方的可重复性。
Phys Imaging Radiat Oncol. 2022 Jun 11;23:8-15. doi: 10.1016/j.phro.2022.06.004. eCollection 2022 Jul.
10
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.1.5T MRI 线性加速器(MR-Linac)和 MR 模拟器设备上扩散加权 MRI 序列在头颈部癌症中的体内和体模重复性及可重复性的前瞻性评估。
Radiother Oncol. 2023 Aug;185:109717. doi: 10.1016/j.radonc.2023.109717. Epub 2023 May 19.

引用本文的文献

1
Anatomical zone and tissue type impacts the repeatability of quantitative MRI parameters and radiomic features for longitudinal monitoring of treatment response in the prostate.解剖区域和组织类型会影响定量MRI参数及影像组学特征在前列腺治疗反应纵向监测中的可重复性。
MAGMA. 2025 Feb 22. doi: 10.1007/s10334-025-01231-9.

本文引用的文献

1
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy.极端和适度低分割磁共振图像引导放射治疗期间前列腺体积的变化
Clin Oncol (R Coll Radiol). 2022 Sep;34(9):e383-e391. doi: 10.1016/j.clon.2022.03.022. Epub 2022 Apr 22.
2
Robust extraction of biological information from diffusion-weighted magnetic resonance imaging during radiotherapy using semi-automatic delineation.在放疗期间使用半自动轮廓描绘从扩散加权磁共振成像中稳健提取生物信息。
Phys Imaging Radiat Oncol. 2022 Mar 7;21:146-152. doi: 10.1016/j.phro.2022.02.014. eCollection 2022 Jan.
3
Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).
前列腺表观扩散系数重复性和可再现性评估:ECOG-ACRIN 研究组(ACRIN 6701)试验。
J Magn Reson Imaging. 2022 Sep;56(3):668-679. doi: 10.1002/jmri.28093. Epub 2022 Feb 10.
4
Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy-A Multicenter Study.磁共振引导放疗期间前列腺癌患者的每日体素内不相干运动(IVIM)——一项多中心研究
Front Oncol. 2021 Aug 13;11:705964. doi: 10.3389/fonc.2021.705964. eCollection 2021.
5
Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy.用于生物图像引导自适应放射治疗的定量磁共振成像
Front Oncol. 2021 Jan 29;10:615643. doi: 10.3389/fonc.2020.615643. eCollection 2020.
6
ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium.Unity MR-Linac 上的 ADC 测量 - Elekta Unity MR-Linac 联盟的建议。
Radiother Oncol. 2020 Dec;153:106-113. doi: 10.1016/j.radonc.2020.09.046. Epub 2020 Oct 2.
7
Adaptive radiotherapy: The Elekta Unity MR-linac concept.自适应放疗:医科达Unity MR直线加速器概念
Clin Transl Radiat Oncol. 2019 Apr 2;18:54-59. doi: 10.1016/j.ctro.2019.04.001. eCollection 2019 Sep.
8
Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator.1.5TMR 直线加速器定量成像的可行性和准确性。
Radiother Oncol. 2019 Apr;133:156-162. doi: 10.1016/j.radonc.2019.01.011. Epub 2019 Jan 28.
9
Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis.使用全病变 ADC 值、偏度和直方图分析对前列腺弥散加权 MRI 的可重复性研究。
Eur J Radiol. 2019 Jan;110:22-29. doi: 10.1016/j.ejrad.2018.11.014. Epub 2018 Nov 17.
10
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.定量成像生物标志物联盟(QIBA)关于提高多中心肿瘤试验中 DWI 和 DCE-MRI 衍生生物标志物精度的建议。
J Magn Reson Imaging. 2019 Jun;49(7):e101-e121. doi: 10.1002/jmri.26518. Epub 2018 Nov 19.